Skip to main content
Premium Trial:

Request an Annual Quote

Shares in Millipore, Molecular Devices Fall

Shares in Millipore and Molecular Devices were the two leading decliners in the BCW Index for the week ended Tuesday, falling 7.4 percent and 5.4 percent, respectively. Millipore’s shares fell after the firm’s investor analyst day, during which it acknowledged some difficulties with its Upstate unit. Agilent led gainers for the week with a 4.7-percent rise.
 
Overall, the Index dropped .2 percent for the tracking period. In comparison, the Dow Jones Industrial Average rose 1.1 percent, the Nasdaq gained 1.8 percent, and the Nasdaq Biotech Index was flat with the previous week.
 
 
BioCommerce Week Index of Diversified
Molecular Biology Tool Companies
Company
Ticker
Current Price
(September 26, 2006)
Last
Price
(September 19, 2006)
% change
Agilent
A
32.94
31.45
4.7
Applied Biosystems
ABI
32.34
33.11
-2.3
Beckman
BEC
57.58
56.77
1.4
Bio-Rad
BIO
71.49
70.24
1.8
Bruker
BRKR
6.69
6.80
-1.6
Fisher Scientific
FSH
79.21
79.46
-0.3
GE
GE
35.44
34.85
1.7
Invitrogen
IVGN
63.45
64.42
-1.5
Millipore
MIL
60.41
65.21
-7.4
Molecular Devices
MDCC
21.84
23.08
-5.4
PerkinElmer
PKI
18.97
18.45
2.8
Qiagen
QGEN
15.41
14.76
4.4
Sigma
SIAL
75.25
73.43
2.5
Stratagene
STGN
6.28
6.40
-1.9
Thermo
TMO
39.72
40.00
-0.7
Waters
WAT
44.26
44.02
0.5
BCW Index Average
41.33
41.40
-0.2

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.